hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

ViiV Healthcare (joint venture Pfizer & GlaxoSmithKline)

ViiV Healthcare website

🔎 Run a search for “ViiV Healthcare (joint venture Pfizer & GlaxoSmithKline)”

Get RSS feed of these results

All stories

11 February 2016

India: MSF supports people living with HIV to oppose Viiv’s attempt to get patents for HIV drugs


See full story

16 December 2014
+ Français - Hide
27 January 2012

Joining a Mother's Fight to End AIDS in Children

Author: Charles Lyons, Huffington Post [USA]

This year's annual World Economic Forum witnessed the launch of a group dedicated to ending pediatric AIDS -- the Business Leadership Council for a Generation Born Free of HIV. The Business Leadership Council is comprised of representatives from...

Read more

30 November 2011

The Medicines Patent Pool: A Powerful Strategy for "Getting to Zero"

Author: Interfaith Center on Corporate Responsibility [USA]

In honor of World AIDS Day...members of the Interfaith Center on Corporate Responsibility (ICCR) reiterate their endorsement of the Medicines Patent Pool (MPP) created by UNITAID, and call upon pharmaceutical companies to share their licenses for life...

Read more

18 July 2011
+ Français - Hide

Author: Médecins Sans Frontières

Selon un rapport publié aujourd'hui par Médecins Sans Frontières (MSF) lors de la Conférence de l'International AIDS Society à Rome, plusieurs compagnies pharmaceutiques ont interrompu les programmes de réduction du coût des médicaments antirétroviraux...

Read more

25 November 2010

Making AIDS Drugs Affordable Here and Abroad

Author: PBS NewsHour

...[C.] Samuel is leading Gilead's global access program, an innovative tiered pricing scheme that sells drugs at full price in developed countries, 70 percent to 90 percent less in middle-income countries like Brazil, and at no profit in the poorest...

Read more

17 June 2010

ViiV Healthcare and amfAR Partner to Optimize HIV Treatment for Infants and Children in Asia

Author: ViiV Healthcare

ViiV Healthcare and TREAT Asia, a Bangkok-based program of amfAR, The Foundation for AIDS Research, announced a…two-year partnership that aims to improve access and optimize the quality of healthcare for infants and children living with HIV across...

Read more